Quality Control Study of Laparoscopic Sentinel Node Biopsy in Early Gastric Cancer
NCT ID: NCT01544413
Last Updated: 2014-12-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
112 participants
INTERVENTIONAL
2012-02-29
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laparoscopic sentinel lymph node biopsy
This is a single armed study. After endoscopic marking using Tc99m HSA and indocyanine green fluid, Laparoscopic sentinel lymph node biopsy was performed and evalute at backtable.
Laparoscopic sentinel lymph node biopsy
During the operation, endoscopic marking was perfomed using Tc 99m HSA and indocyanine green around tumor. Then we identify the sentinel lymph node with laparoscopic probe. Laparoscopic sentinel lymph nodes were dissedted and evaluated them at the backtable in the operating room.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Laparoscopic sentinel lymph node biopsy
During the operation, endoscopic marking was perfomed using Tc 99m HSA and indocyanine green around tumor. Then we identify the sentinel lymph node with laparoscopic probe. Laparoscopic sentinel lymph nodes were dissedted and evaluated them at the backtable in the operating room.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* clinical stage T1-2N0
* long diameter of tumor \<4cm
* distance between tumor and pylorus or cardia \>2cm
* age: 20-80
* ECOG: 1 or 0
* patients will undergo laparoscopic gastrectomy
Exclusion Criteria
* no indication for surgery for cardiovascular, pulmonary disease
* pregancy
* drug allergy or previous abdominal surgery, radiotherpy
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Cancer Center, Korea
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Keun Won Ryu
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Keun Won Ryu, Doctor
Role: PRINCIPAL_INVESTIGATOR
National Cancer Center, Korea
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chonnam National University Hwasun Hospital
Hwasun, Chonnam, South Korea
National Cancer Center, Korea
Goyang-si, Gyeonggi-do, South Korea
Ajou University School of Medicine
Suwon, Gyeonggi-do, South Korea
Gyeongsang National University
Jinju, Gyeongsangnam-do, South Korea
Korea University Guro Hospital
Seoul, Seoul, South Korea
Yonsei Univeristy College of Medicine
Seoul, Seoul, South Korea
Hallym University Sacred Heart Hospital
Anyang, , South Korea
Soonchunhyang University Bucheon Hospital
Bucheon-si, , South Korea
Dong-A University College of Medicine
Busan, , South Korea
Dongnam Institute of Radiological and Medical Science
Busan, , South Korea
Keimyung University School of Medicine
Daegu, , South Korea
Korea University College of Medicine
Seoul, , South Korea
Kyung Hee University Gangdong Hospital
Seoul, , South Korea
Seoul St. Mary's Hospital
Seoul, , South Korea
Yeouido St. Mary's Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SENORITA-2012
Identifier Type: -
Identifier Source: org_study_id